02/05/2024
NebuFlow, a Scottish firm specialising in innovative inhaled drug delivery systems, has successfully raised £4.7 million in funding.
This substantial investment underscores the potential of NebuFlow’s technology to transform respiratory disease treatment across the globe.
Let's take a look at what it means 👇
🔵 The funds will enable significant advancements in NebuFlow’s R&D efforts, accelerating the development of new and improved drug delivery technologies.
🔵 This funding round opens the door to new partnerships, enhancing NebuFlow’s ability to collaborate with leading healthcare providers and researchers.
🔵 The investment will assist in scaling the technology for broader market application, aiming to reach more patients and healthcare systems worldwide.
To find out more, read the full article here: https://buff.ly/3wheJjk